SORMANI, MARIA PIA
 Distribuzione geografica
Continente #
EU - Europa 47.175
AS - Asia 1.473
SA - Sud America 244
NA - Nord America 228
AF - Africa 36
OC - Oceania 1
Totale 49.157
Nazione #
IT - Italia 47.116
SG - Singapore 712
CN - Cina 365
VN - Vietnam 263
US - Stati Uniti d'America 176
BR - Brasile 160
HK - Hong Kong 55
MX - Messico 45
AR - Argentina 41
ID - Indonesia 15
ZA - Sudafrica 13
EC - Ecuador 12
RU - Federazione Russa 12
IQ - Iraq 11
VE - Venezuela 11
BD - Bangladesh 10
KE - Kenya 7
FR - Francia 6
AT - Austria 5
DE - Germania 5
IN - India 5
PE - Perù 5
PK - Pakistan 5
SA - Arabia Saudita 5
UA - Ucraina 5
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
EG - Egitto 4
NL - Olanda 4
AL - Albania 3
JO - Giordania 3
KR - Corea 3
SE - Svezia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
GB - Regno Unito 2
GT - Guatemala 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
MA - Marocco 2
MM - Myanmar 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
FI - Finlandia 1
GF - Guiana Francese 1
HN - Honduras 1
JM - Giamaica 1
JP - Giappone 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
NE - Niger 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TR - Turchia 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 49.157
Città #
Genova 30.364
Genoa 10.402
Rapallo 3.390
Vado Ligure 2.824
Singapore 357
Bordighera 104
Beijing 96
Ho Chi Minh City 96
Ashburn 77
Hanoi 59
Hong Kong 53
Mexico City 31
Tianjin 28
Haiphong 17
New York 16
São Paulo 14
San Jose 11
Da Nang 10
Hải Dương 8
Guangzhou 7
Johannesburg 7
Phoenix 7
Can Tho 6
Nairobi 6
Baghdad 5
Los Angeles 5
Medford 5
Biên Hòa 4
Brasília 4
Buenos Aires 4
Changsha 4
Curitiba 4
Guayaquil 4
Itaquaquecetuba 4
Moscow 4
Orem 4
Quito 4
Recife 4
Rio de Janeiro 4
Amman 3
Boardman 3
Bogotá 3
Brooklyn 3
Bắc Ninh 3
Caracas 3
Dallas 3
Frankfurt am Main 3
Governador Valadares 3
Itatiba 3
Karachi 3
Lấp Vò 3
Milan 3
Ninh Bình 3
Orangeburg 3
Porto Alegre 3
Quảng Ngãi 3
Riyadh 3
Thái Nguyên 3
Tây Ninh 3
Villa Ballester 3
Vĩnh Long 3
Vĩnh Tường 3
Americana 2
Aracaju 2
Baku 2
Banjar Badung 2
Bari 2
Belo Horizonte 2
Boston 2
Cachoeiro de Itapemirim 2
Cairo 2
Carapicuíba 2
Caxias do Sul 2
Chongqing 2
Cotia 2
Duhok 2
Ezeiza 2
Francavilla al Mare 2
Frutal 2
Guatemala City 2
Houston 2
Huntington 2
Jakarta 2
Jinan 2
La Paz 2
Lima 2
Montevideo 2
Newark 2
Nuremberg 2
Phủ Lý 2
Piracicaba 2
Puerto Madryn 2
Qingdao 2
Santa Clara 2
Santa Rosa 2
Shijiazhuang 2
Sorocaba 2
São Bernardo do Campo 2
Tel Aviv 2
Thái Bình 2
Totale 48.198
Nome #
High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva. 263
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 220
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies 210
A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosis. 191
Clinical epidemiology of ALS in Liguria, Italy. 187
Evaluation of insulin resistance in a cohort of HIV-infected youth. 185
Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysis 185
Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: Interim report of a prospective comparative trial 185
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 180
Breast Density Assessment Using a 3T MRI System: Comparison among Different Sequences 180
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 178
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 178
Different MRI patterns in MS worsening after stopping fingolimod 178
Can we measure long-term treatment effects in multiple sclerosis? 174
Indirect comparisons of treatment effects in multiple sclerosis. 173
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits. 171
Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS. 171
Defining the clinical course of multiple sclerosis: the 2013 revisions. 170
Modelling the distribution of cortical lesions in multiple sclerosis. 170
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 170
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial. 167
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 166
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis 166
Use of maraviroc in clinical practice: a multicenter observational study 165
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 165
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. 164
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 164
Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study. 164
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. 164
A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2) 164
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 161
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 161
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 161
Quantitative assessment of finger motor performance: Normative data 161
99mTc-white cell scanning to detect gut inflammation in children with inflammatory bowel diseases or spondyloarthropathies 160
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. 160
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. 160
Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients. 160
Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis 159
BCR-ABL nuclear entrapment kills human CML cells: ex-vivo study on 35 patients with the combination of Imatynib Mesylate and Leptomycin B 159
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. 158
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment 157
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach 157
Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies. 156
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 156
A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma. 155
Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS). 155
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study. 154
Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy 154
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 154
Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study 153
Optimizing therapy early in multiple sclerosis: An evidence-based view 153
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 153
The influence of slice orientation on brain MRI lesion load measurement in multiple sclerosis 151
Age-related changes in Conventional, Magnetization Transfer, and Diffusion-Tensor MR Imaging Findings: Study with Whole-Brain Tissue Histogram Analysis. 151
Body mass index in Th1 and Th2 diseases. 151
Statistical issues related to the use of MRI data in multiple sclerosis 150
Treatment decisions in multiple sclerosis - insights from real-world observational studies. 150
Single-Port Versus Conventional Laparoscopic Cholecystectomy: Better Cosmesis at the Price of an Increased Incisional Hernia Rate? 150
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain 149
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 149
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 149
Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis 148
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy 147
The most frequently asked question to a statistician: The sample size 146
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 146
Dosimetric predictors of diarrhea during radiotherapy for prostate cancer. 146
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: yes. 145
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Establishing disease prognosis and monitoring patients 145
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection. 144
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children 144
Approved drugs for multiple sclerosis: The challenge of choice 144
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis 144
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 144
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal study. 143
Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis. 143
Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging 143
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. 143
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 143
Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis 143
The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis 142
Scoring treatment response in patients with relapsing multiple sclerosis. 142
Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. 141
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. 141
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results 140
Defining and scoring response to IFN-β in multiple sclerosis. 140
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Clinical implementation in the diagnostic process 140
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis 140
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution. 140
Radiologically isolated syndrome: 5-year risk for an initial clinical event. 140
A Comprehensive Review on Copemyl(®) 139
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 139
HPV-related oropharyngeal carcinoma with Overt Level II and/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V. 138
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up 138
Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis 138
Clinical activity after fingolimod cessation: Disease reactivation or rebound? 138
A magnetization transfer histogram study of normal appearing brain tissue in multiple sclerosis 137
A conventional and magnetization transfer MRI study of the cervical cord in patients with multiple sclerosis 137
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. 137
A composite score to predict short-term disease activity in patients with relapsing-remitting MS 137
Totale 15.720
Categoria #
all - tutte 172.489
article - articoli 171.512
book - libri 0
conference - conferenze 977
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 344.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.310 0 0 0 0 0 302 224 390 289 482 301 322
2021/20225.124 139 294 581 477 146 361 317 1.214 236 422 299 638
2022/20234.155 462 197 50 416 709 795 19 308 765 58 324 52
2023/20242.426 116 354 57 216 199 513 181 158 145 69 135 283
2024/20256.979 157 607 270 404 944 772 726 953 305 362 620 859
2025/20265.402 1.378 316 855 1.078 1.482 293 0 0 0 0 0 0
Totale 50.213